2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on Stage 3 EGFR+ NSCLC: Should Osimertinib Be Considered for Patients With EGFR Exon 21 Mutation in Adjuvant Setting?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
John Vu
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
John Vu
225 views
September 28, 2020
Comments 0
Login to view comments.
Click here to Login
Lung